輸入代號或公司名稱後按 Enter
6576

逸達

-0.30 (-0.37%)最後更新 2026-09-11
台灣 · 上櫃 · 生技醫療業
80.80161成交張數577.14本益比10.00股價淨值比0.00%殖利率2026-09-11資料日期

每股盈餘

柱為單季 EPS,線為近四季合計;近十年

季度單季 EPS年增近四季 EPS歸屬母公司淨利(億)淨利率ROE(季)ROE(近四季)
2026Q2-0.790.14-1.24-68.1%-9.28%2.00%
2026Q12.59-1.214.07506.7%35.01%-13.45%
2025Q4-0.92-5.70-1.46-280.3%-14.69%-69.85%
2025Q3-0.74-8.30-1.14-72.8%-11.23%-138.70%
2025Q2-2.14-9.82-3.29-295.1%-28.64%-143.98%
2025Q1-1.90-8.89-2.93-265.3%-20.02%-101.24%
2024Q4-3.52-7.87-4.89-347.9%-42.46%-76.04%
2024Q3-2.26-6.88-3.08-384.9%-36.18%-81.68%
2024Q2-1.21-6.34-1.64-174.5%-15.29%-61.48%
2024Q1-0.88-7.52-1.20-115.1%-9.99%-102.99%
2023Q4-2.53-8.14-3.39-494.8%-24.02%-96.17%
2023Q3-1.72-7.35-2.37-389.6%-14.04%-67.59%
2023Q2-2.39-1374.9%-7.00-2.82-752.1%-22.19%-54.81%
2023Q1-1.50-4.42-1.79-631.0%-21.63%-54.09%
2022Q4-1.74-3.95-2.08-2132.6%-20.64%-42.37%
2022Q3-1.37-3.83-1.64-906.3%-13.95%-35.39%
2022Q20.19-3.920.2210.5%1.77%-32.33%
2022Q1-1.03-4.47-1.22-182.6%-9.66%-36.83%
2021Q4-1.62-4.79-1.93-43323.8%-13.79%-36.15%
2021Q3-1.46-3.73-1.73-156084.7%-11.09%-42.16%
2021Q2-0.37-4.22-0.44-28.4%-2.63%-39.98%
2021Q1-1.34-5.25-1.59-221.0%-9.07%-45.33%
2020Q4-0.57-4.97-0.53-27.2%-4.44%-37.48%
2020Q3-1.95-5.24-2.02-27996.0%-33.65%-71.09%
2020Q2-1.39-5.10-1.45-20.17%-58.33%
2020Q1-1.07-5.54-1.10-315.1%-13.04%-88.55%
2019Q4-0.83-4.92-0.89-1168.0%-9.42%-69.88%
2019Q3-1.81-5.93-1.83-17.12%-68.94%
2019Q2-1.83-1.74-21.50%
2019Q1-0.45-0.41-60.6%-8.50%
2018Q4-1.84-1.70-29.17%
2018Q3-1.34-1.26-1519.6%